TNXP - Tonix Pharma Net earnings per share (EPS TTM)

Symbol and logo of brand tonixpharma.com (TNXP)

Tonix Pharmaceuticals profitability is vulnerable due to global supply chain complexities and patent disputes. The company's TTM net income per share reflects the impact of external factors, where -12.17 represents the latest metric reading. A lack of stable cash flows leaves the biotech firm dependent on investment, forcing management to implement restructuring and focus on final-stage trials to preserve liquidity.

TNXP (Tonix Pharmaceuticals) Net earnings per one share for the last twelve months history from 07/04/2022 to 11/17/2026

Tonix Pharmaceuticals Holding (TNXP) - metric breakdowns and financial figures

Basic company analysis:TNXP - Tonix Pharmaceuticals Inc.
Flagship merchandise of Tonix Pharmaceuticals Inc.

This indicator calculates the rolling net income per share over the last four quarters, allowing investors to assess the actual return on equity while stripping out reporting period volatility. By analyzing the EPS TTM fundamental metric, one can track how the costs of developing drugs for neurological disorders and the attraction of investment impact the final shareholder value in Tonix Pharmaceuticals (TNXP).

Direct competitors

Haleon - Net earnings per share (EPS TTM)|Kenvue - Earnings per share for the last four quarters|VRNA: Net earnings per share (EPS TTM)|Jyong Biotech Corp - Earnings per share for the trailing year|LGND (Ligand Pharmaceuticals Incorporated) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months amneal.com AMRX|Earnings per share for the last twelve months Perrigo (PRGO)|ALVO (Alvotech SA) - Earnings per share for the trailing year|Earnings per share for the last twelve months Liquidia Technologies LQDA|Net earnings per share for the trailing year Galapagos Genomics|ANIP - Earnings per share for the last twelve months|MNKD - Net earnings per share (EPS TTM)|Amphastar Pharmaceuticals (AMPH) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Pacira BioSciences, Inc.|Net earnings per share for the last 12 months SPRY|TBPH: Earnings per share for the trailing year|Earnings per share for the last twelve months aquestive.com (AQST)|Net earnings per share (EPS TTM) scPharmaceuticals, Inc. (SCPH)|Earnings per share for the last twelve months tectonictx.com TECX|Earnings per share for the trailing year SXTC|Eupraxia Pharmaceuticals, Inc. - Net earnings per share (EPS TTM)|BHST: Earnings per share for the last twelve months|invizyne.com (EXOZ) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months ORMP (Oramed)|ENTX (Entera Bio) - Net earnings per share (EPS TTM)|HYFT: Earnings per share for the trailing year|Net earnings per share (EPS TTM) ABVC|Cumberland Pharmaceuticals - Earnings per share for the last 12 months|Earnings per share for the last twelve months Quantum BioPharma Ltd. QNTM|FGEN: Earnings per share for the last 12 months|TELO - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Rani Therapeutics Holdings|SNYR: Net earnings per share (EPS TTM)|Earnings per one share for the last 12 months RLYB (Rallybio Corp.)|LEXX (Lexaria Bioscience Corp.) - Net earnings per share (EPS TTM)|pulmatrix.com (PULM) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Pheton (PTHL)|Net earnings per share for the last four quarters Aptorum Group Ltd|Net earnings per share (EPS TTM) LYRA (Lyra Therapeutics Inc)|Impact BioMedical - Earnings per share for the last twelve months|TNF Pharmaceuticals - Net earnings per share (EPS TTM)|YCBD - Net earnings per share (EPS TTM)|PRFX: Net earnings per share (EPS TTM)|CYTO: Earnings per share for the last four quarters|LIPO (Lipella Pharma) - Net earnings per share (EPS TTM)|OPTN: Earnings per share for the trailing year|Net earnings per share (EPS TTM) PIRS|PROC (procapsgroup.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months Petros Pharmaceuticals, Inc. PTPI|Qilian International Holding - Earnings per share for the last twelve months|SLRN - Earnings per share for the last twelve months|Earnings per one share for the last 12 months TFFP